| # | Drug | Count |
|---|---|---|
| 0 | DARUNAVIR ETHANOLATE AND COBICISTAT | 17 |
| 1 | DARUNAVIR | 16 |
| 2 | ABACAVIR SULFATE | 15 |
| 3 | COBICISTAT | 15 |
| 4 | DARUNAVIR 600 MG | 15 |
| 5 | DARUNAVIR 800 MG | 15 |
| 6 | LAMIVUDINE | 15 |
| 7 | LAMIVUDINE ORAL | 15 |
| 8 | ADALIMUMAB | 11 |
| 9 | ABACAVIR | 9 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DARUNAVIR ETHANOLATE AND COBICISTAT | 17 | 0.0096 |
| 1 | ABACAVIR AND LAMIVUDINE | 1 | 0.0050 |
| 2 | DARUNAVIR 600 MG | 15 | 0.0024 |
| 3 | BETAXOLOL HYDROCHLORIDE | 1 | 0.0019 |
| 4 | ABACAVIR SULFATE | 15 | 0.0015 |
| 5 | RALTEGRAVIR | 6 | 0.0011 |
| 6 | ILOPROST | 1 | 0.0011 |
| 7 | DARUNAVIR | 16 | 0.0011 |
| 8 | CEFOXITIN SODIUM | 1 | 0.0007 |
| 9 | CLOMIPHENE CITRATE | 1 | 0.0007 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Prostacycline [EPC] | 1 | 0.0011 |
| 1 | Plasma Kallikrein Inhibitor [EPC] | 1 | 0.0004 |
| 2 | Protease Inhibitor [EPC] | 17 | 0.0004 |
| 3 | Anthelmintic [EPC] | 1 | 0.0003 |
| 4 | Oxytocic [EPC] | 1 | 0.0003 |
| 5 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 16 | 0.0003 |
| 6 | Cytochrome P450 3A Inhibitor [EPC] | 19 | 0.0003 |
| 7 | Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] | 2 | 0.0003 |
| 8 | Human Immunoglobulin G [EPC] | 5 | 0.0002 |
| 9 | Gadolinium-based Contrast Agent [EPC] | 1 | 0.0002 |